• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of cytotechspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
Cytotechnology. Jan 2005; 47(1-3): 11–17.
PMCID: PMC3449815

Differentiation of Human Bone Marrow Mesenchymal Stem Cells to Chondrocytes for Construction of Three-dimensional Cartilage Tissue

Abstract

A differentiation method of human bone marrow mesenchymal stem cells (MSCs) to chondrocytes was developed for the construction of a three-dimensional (3D) cartilage tissue. The adhesive cells, which were isolated from a human bone marrow aspirate were embedded in type I collagen in a poly-l-lactate-glycolic acid copolymer (PLGA) mesh and cultivated for 4 week together with growth factors. The degree of cellular differentiation was estimated by quantitative RT-PCR of aggrecan and type II collagen mRNAs and by staining with Safranin O. The 3D culture showed a higher degree of differentiation even without growth factors than the conventional pellet culture with growth factors, namely, dexamethasone and transforming growth factor (TGF)-β 3. The 3D culture for 2 week with the combined addition of dexamethasone, TGF-β 3, and insulin-like growth factor (IGF)-I reached a 30% expression of aggrecan mRNA compared with that in primary human chondrocytes, while the aggrecan mRNA expression in the conventional pellet culture was less than 2%. The sequential two-step differentiation cultivation, during which the cells were cultivated in 3D for 1 week after the conventional two-dimensional (2D) culture for 1 week, could markedly accelerate the expression of aggrecan mRNA compared with the 3D cultivation for 2 week.

Keywords: Chondrocyte, Differentiation, Mesenchymal stem cell, Three-dimension

Full Text

The Full Text of this article is available as a PDF (267K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Alastair M., Mackey Stephen C., Beck J., Mary M., Frank P.B., Clinton O.C., Mark F.P. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng. 1998;4(4):415–428. [PubMed]
  • Allison A.W., Alan J.N., Brent D.B.-T., Janice W. Effect of transforming growth factor-β 1 on chondrogenic differentiation of cultured equine mesenchymal stem cells. Am. J. Veterinary Res. 2000;9(61):1003–1010. [PubMed]
  • Allison A.W., Brent D.B.-T., Lisa A.F., Stephen J.B., Janice W., Alan J.N. Chondrocytic differentiation of mesenchymal stem cells sequentially exposed to transforming growth factor-β 1 in monolayer and insulin-like growth factor-I in a three-dimensional matrix. J. Orthop. Res. 2001;19:738–749. [PubMed]
  • Barry F.P., Boynton R.E., Haynesworth S., Murphy J.M., Zaia J. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105) Biochem. Biophys. Res. Commun. 1999;265:134–139. doi: 10.1006/bbrc.1999.1620. [PubMed] [Cross Ref]
  • Bruder S.P., Jaiswal N., Haynesworth S.E. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J. Cell. Biochem. 1997;64:278–294. doi: 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F. [PubMed] [Cross Ref]
  • Bruder S.P., Kurth A.A., Shea M., Hayes W.C., Jaiswal N., Kadiyala S. Bone regeneration by implantation of purifiedculture-expanded human mesenchymal stem cells. J. Orthop. Res. 1998;16:155–162. doi: 10.1002/jor.1100160202. [PubMed] [Cross Ref]
  • Caplan A.I. Mesenchymal stem cells. J. Orthop. Res. 1991;9:641–650. doi: 10.1002/jor.1100090504. [PubMed] [Cross Ref]
  • Caplan A.I., Fink D.J., Goto T., Linton A.E., Young R.G., Wakitani S., Goldberg V.M., Haynesworth S.E. Mesenchymal stem cells and tissue repair. In: Jackson D.W., editor. The Anterior Cruciate Ligament: Current and Future Concepts. New York: Raven Press Ltd.; 1993. pp. 405–417.
  • Dennis J.E., Caplan A.I. Differentiation potential of conditionally immortalized mesenchymal progenitor cells from adult marrow of a H-2Kb-tsA58 transgenic mouse. J._Cell. Physiol. 1996;167:523–538. [PubMed]
  • Frank B., Raymond E.B., Beishan L., Murphy J.M. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp. Cell Res. 2001;268:189–200. [PubMed]
  • Lazarus H.M., Caplan A.I. Ex-vivo expansion and subsequent infusion of human bone-marrow-derived stromal progenitor cells (mesenchymal stem cells) – implications for therapeutic use. Bone Marrow Transpl. 1995;16:557–564. [PubMed]
  • Majumdar M.K., Haynesworth S.E., Thiede M.A., Marshak D.R., Caplan A.I., Gerson S.L. Culture-expanded human mesenchymal stem cells (MSCs) express cytokines and support hematopoiesis in vitro. Blood. 1995;86:494a.
  • Manas Kumar M., Eunice W., Elisabeth Ann M. BMP-2 and BMP-9 promote chondrogenic differentiation of human multipotential mesenchymal cells and overcome the inhibitory effect of IL-1. J. Cell. Physiol. 2001;189:275–284. [PubMed]
  • Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multileneage potential of adult human mesenchymal stem cells. Science. 1999;28:143–147. [PubMed]
  • Ponticiello M.S., Schinagl R.M., Kadiyala S., Barry F.P. Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy. J. Biomed. Mater. Res. 2000;52:246–255. doi: 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W. [PubMed] [Cross Ref]
  • Takagi M., Nakamura T., Matsuda C., Hattori T., Wakitani S., Yoshida T. In vitro proliferation of human bone marrow mesenchymal stem cells employing donor serum and basic fibroblast growth factor. Cytotechnol. 2003;43:89–96. doi: 10.1023/B:CYTO.0000039911.46200.61. [PMC free article] [PubMed] [Cross Ref]
  • Takagi M., Fukui Y., Wakitani S., Yoshida T. Novel three-dimensional cultivation of primary porcine chondrocytes combined with collagen gel and PLGA mesh. J. Biosci. Bioeng. 2004;98:477–481. [PubMed]
  • Wakitani S., Goto T., Pineda S.J., Young R.G., Mansour J.M., Caplan A.I., Goldberg V.M. Mesenchymal cell-based repair of large full-thickness defects of articular-cartilage. J. Bone Joint Surg. Am. 1994;76:579–592. [PubMed]
  • Wakitani S., Saito T., Caplan A.I. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve. 1995;18:1417–1426. doi: 10.1002/mus.880181212. [PubMed] [Cross Ref]
  • Young R.G., Butler D.L., Weber W., Caplan A.I., Gordon S.L., Fink D.J. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J. Orthop. Res. 1998;16:406–413. doi: 10.1002/jor.1100160403. [PubMed] [Cross Ref]

Articles from Cytotechnology are provided here courtesy of Springer Science+Business Media B.V.

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • PubMed
    PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...